Mixed Dementia
8
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Comprehensive Assessment of Neurodegeneration and Dementia
Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers
Telehealth-enabled Integrated Palliative Care for People With Dementia
Feasibility of Passive Data Collection in Dementia Subjects With Agitation
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Mirtazapine in Alzheimer-associated Weight Loss